To evaluate the EGFR mutations in patients with NSCLC and newly diagnosed brain metastasis and to examine the effect of EGFR tyrosine kinase inhibitors on brain metastasis harboring CSF‐tested uncommon EGFR mutations. Here, EGFR is linked to non-small cell lung carcinoma.